CerqueiraJJCompstonDASGeraldesR, et al. Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?J Neurol Neurosurg Psychiatry2018; 89(8): 844–850, https://jnnp.bmj.com/content/89/8/844
3.
LazzarottoAHamzaouiMToniettoM, et al. Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis. Brain2024; 147(4): 1331–1343.
4.
CalabreseMGasperiniCTortorellaC, et al. “Better explanations” in multiple sclerosis diagnostic workup: A 3-year longitudinal study. Neurology2019; 92(22): E2527–E2537, https://pubmed.ncbi.nlm.nih.gov/31043476/
5.
YamoutBIKhourySJAyyoubiN, et al. Alternative diagnoses in patients referred to specialized centers for suspected MS. Mult Scler Relat Disord2017; 18: 85–89, https://pubmed.ncbi.nlm.nih.gov/29141828/
6.
WangYBou RjeilyNKoshorekJ, et al. Clinical and radiologic characteristics associated with multiple sclerosis misdiagnosis at a tertiary referral center in the United States. Mult Scler2023; 29(11–12): 1428–1436, https://pubmed.ncbi.nlm.nih.gov/37698023/
7.
GaitánMISanchezMFarezMF, et al. The frequency and characteristics of multiple sclerosis misdiagnosis in Latin America: A referral center study in Buenos Aires, Argentina. Mult Scler2022; 28(9): 1373–1381, https://pubmed.ncbi.nlm.nih.gov/34971521/
8.
KaiseyMSolomonAJLuuM, et al. Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers. Mult Scler Relat Disord2019; 30: 51–56, https://pubmed.ncbi.nlm.nih.gov/30738280/
CagolACorteseRBarakovicMet al. MAGNIMS study group. Diagnostic performance of cortical lesions and the central vein sign in multiple sclerosis. JAMA Neurol2024; 81: 143–153. https://pubmed.ncbi.nlm.nih.gov/38079177/
